IPM identifies drug therapy risks in patients, suggesting improvements to safety through guideline recommendations.
Background: The Individual Pharmacotherapy Management (IPM) systematically identifies and rectifies drug-related risks, including those arising from guideline-based recommendations, to enhance patient safety [ref:1], [ref:2], [ref:3], [ref:4], [ref:5], [for full text, please go to the a.m. URL]
No takes yet. Share an insight, caveat, or question.
Wolf Ursula (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: